EQS-Adhoc: Kommentar zu Medienbericht
|
EQS-Ad-hoc: Evotec SE / Schlagwort(e): Sonstiges Ad hoc: Kommentar zu Medienbericht Hamburg – Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) Die Evotec SE ("Gesellschaft") stellt mit Blick auf einen Medienbericht fest, dass sie ohne vorherige Kontaktaufnahme vom börsennotierten US-Biotechnologieunternehmen Halozyme Therapeutics Inc. eine unverbindliche Interessenbekundung bezogen auf ein an die Aktionäre der Gesellschaft gerichtetes Übernahmeangebot mit einem Angebotspreis von EUR 11,00 je Aktie erhalten hat. Die Gesellschaft wird diese Interessenbekundung sorgfältig analysieren, über weitere Schritte entscheiden und den Kapitalmarkt entsprechend den rechtlichen Anforderungen weiter informieren. – Ende der Ad hoc-Mitteilung – Kontakt: Volker Braun, EVP Head of Global Investor Relations & ESG, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Deutschland, Tel.: +49 (0) 151 1940 5058 (m), volker.braun@evotec.com
Ende der Insiderinformation
14.11.2024 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen. |
| Sprache: | Deutsch |
| Unternehmen: | Evotec SE |
| Manfred Eigen Campus / Essener Bogen 7 | |
| 22419 Hamburg | |
| Deutschland | |
| Telefon: | +49 (0)40 560 81-0 |
| Fax: | +49 (0)40 560 81-222 |
| E-Mail: | info@evotec.com |
| Internet: | www.evotec.com |
| ISIN: | DE0005664809 |
| WKN: | 566480 |
| Indizes: | SDAX, TecDAX |
| Börsen: | Regulierter Markt in Berlin, Frankfurt (Prime Standard); Freiverkehr in Düsseldorf, Hamburg, Hannover, München, Stuttgart, Tradegate Exchange; Nasdaq |
| EQS News ID: | 2030647 |
| Ende der Mitteilung | EQS News-Service |
|
|
2030647 14.11.2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
| Sales1 | 375,41 | 446,44 | 500,92 | 618,03 | 751,45 | 781,43 | 895,00 | |
| EBITDA1,2 | 95,46 | 123,14 | 51,77 | 101,65 | 102,51 | 66,35 | 140,00 | |
| EBITDA-Margin3 | 25,43 | 27,58 | 10,34 | 16,45 | 13,64 | 8,49 | 15,64 | |
| EBIT1,4 | 77,46 | 62,59 | 48,52 | 41,00 | 20,85 | -47,51 | 30,00 | |
| EBIT-Margin5 | 20,63 | 14,02 | 9,69 | 6,63 | 2,78 | -6,08 | 3,35 | |
| Net Profit (Loss)1 | 84,06 | 37,23 | 6,25 | 215,51 | -175,66 | -83,91 | 17,00 | |
| Net-Margin6 | 22,39 | 8,34 | 1,25 | 34,87 | -23,38 | -10,74 | 1,90 | |
| Cashflow1,7 | 156,24 | 42,22 | 44,72 | 122,24 | 203,11 | 36,44 | 0,00 | |
| Earnings per share8 | 0,46 | 0,25 | 0,04 | 1,30 | -0,99 | -0,47 | 0,11 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: BDO
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Evotec | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| 566480 | DE0005664809 | SE | 1.492,34 Mio € | 10.11.1999 | Halten | 9F5FMXGW+WH |
| PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 15,86 | 35,60 | 0,45 | 72,46 | 1,54 | 40,95 | 1,91 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 10.06.2024 | 07.05.2025 | 13.08.2025 | 06.11.2024 | 17.04.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +9,11% | -3,44% | -60,50% | -60,07% | -35,35% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
